APA (7th ed.) Citation

Wada, H., Yamamoto, A., Shiraki, K., & Shimpo, H. (2023). Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. <i>Diagnostics</i> 2023, <i>13</i>, 2299”. MDPI AG.

Chicago Style (17th ed.) Citation

Wada, Hideo, Akitaka Yamamoto, Katsuya Shiraki, and Hideto Shimpo. Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto Et Al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. <i>Diagnostics</i> 2023, <i>13</i>, 2299”. MDPI AG, 2023.

MLA (9th ed.) Citation

Wada, Hideo, et al. Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto Et Al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. <i>Diagnostics</i> 2023, <i>13</i>, 2299”. MDPI AG, 2023.